LOADING
Comparing NVIDIA Corporation (NVDA) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $5.27T | $454.4B |
| P/E Ratio | 27.6 | 72.0 |
| Forward P/E | 24.1 | 15.8 |
| PEG Ratio | 0.56 | 0.52 |
| EPS | $7.90 | $3.57 |
| Revenue Growth (YoY) | 105.9% | 10.2% |
| Profit Margin | 63.7% | 9.8% |
| Return on Equity | 117.2% | 62.3% |
| Dividend Yield | 0.13% | 2.68% |
| Beta | 2.22 | 0.28 |
| 52-Week High | $236.00 | $267.47 |
| 52-Week Low | $163.90 | $189.40 |
| Volume | -- | -- |
NVIDIA Corporation is the larger company by market capitalization. NVIDIA Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.